Citadel Advisors’s Fortress Biotech FBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $503K | Buy |
+180,289
| New | +$613K | ﹤0.01% | 9293 |
|
|
2025
Q3 | – | Sell |
-123,892
| Closed | -$313K | – | 13128 |
|
|
2025
Q2 | $230K | Buy |
123,892
+110,999
| +861% | +$192K | ﹤0.01% | 10393 |
|
|
2025
Q1 | $20.1K | Sell |
12,893
-162,868
| -93% | -$287K | ﹤0.01% | 13139 |
|
|
2024
Q4 | $356K | Buy |
175,761
+140,198
| +394% | +$254K | ﹤0.01% | 9313 |
|
|
2024
Q3 | $51.4K | Buy |
35,563
+26,268
| +283% | +$50K | ﹤0.01% | 11880 |
|
|
2024
Q2 | $15.9K | Buy |
+9,295
| New | +$16.8K | ﹤0.01% | 12808 |
|
|
2023
Q3 | – | Sell |
-1,129
| Closed | -$7.75K | – | 14523 |
|
|
2023
Q2 | $9.32K | Buy |
1,129
+1,013
| +873% | +$10K | ﹤0.01% | 13259 |
|
|
2023
Q1 | $1.42K | Buy |
+116
| New | +$1.38K | ﹤0.01% | 14302 |
|
|
2022
Q3 | – | Sell |
-15,771
| Closed | -$199K | – | 12892 |
|
|
2022
Q2 | $199K | Buy |
15,771
+4,868
| +45% | +$72.1K | ﹤0.01% | 10692 |
|
|
2022
Q1 | $222K | Buy |
10,903
+5,199
| +91% | +$142K | ﹤0.01% | 11275 |
|
|
2021
Q4 | $214K | Buy |
5,704
+1,957
| +52% | +$87.3K | ﹤0.01% | 11708 |
|
|
2021
Q3 | $181K | Buy |
3,747
+685
| +22% | +$33.4K | ﹤0.01% | 12120 |
|
|
2021
Q2 | $164K | Buy |
+3,062
| New | +$185K | ﹤0.01% | 12402 |
|
|
2019
Q3 | – | Sell |
-898
| Closed | -$20K | – | 9321 |
|
|
2019
Q2 | $20K | Buy |
+898
| New | +$23.1K | ﹤0.01% | 8947 |
|
|
2019
Q1 | – | Sell |
-860
| Closed | -$11K | – | 9436 |
|
|
2018
Q4 | $11K | Sell |
860
-1,142
| -57% | -$19.1K | ﹤0.01% | 8911 |
|
|
2018
Q3 | $48K | Buy |
+2,002
| New | +$64.1K | ﹤0.01% | 8813 |
|
|
2018
Q2 | – | Sell |
-1,852
| Closed | -$126K | – | 8943 |
|
|
2018
Q1 | $126K | Buy |
+1,852
| New | +$117K | ﹤0.01% | 7629 |
|
|
2017
Q4 | – | Sell |
-1,520
| Closed | -$101K | – | 8092 |
|
|
2017
Q3 | $101K | Buy |
+1,520
| New | +$102K | ﹤0.01% | 7026 |
|
|
2016
Q3 | – | Sell |
-942
| Closed | -$38K | – | 7361 |
|
|
2016
Q2 | $38K | Sell |
942
-434
| -32% | -$20.2K | ﹤0.01% | 6462 |
|
|
2016
Q1 | $64K | Buy |
+1,376
| New | +$58.1K | ﹤0.01% | 6181 |
|
|
2015
Q4 | – | Sell |
-661
| Closed | -$26K | – | 8836 |
|
|
2015
Q3 | $26K | Buy |
+661
| New | +$30.9K | ﹤0.01% | 8009 |
|
|
2015
Q2 | – | Sell |
-332
| Closed | -$17K | – | 8818 |
|
|
2015
Q1 | $19K | Buy |
+332
| New | +$13.8K | ﹤0.01% | 7941 |
|
|
2014
Q3 | – | Sell |
-454
| Closed | -$12K | – | 8192 |
|
|
2014
Q2 | $12K | Sell |
454
-1,280
| -74% | -$33.7K | ﹤0.01% | 7517 |
|
|
2014
Q1 | $51K | Buy |
+1,734
| New | +$67.6K | ﹤0.01% | 6765 |
|
|
2013
Q4 | – | Sell |
-1,212
| Closed | -$46.8K | – | 7040 |
|
|
2013
Q3 | $128K | Buy |
+1,212
| New | +$149K | ﹤0.01% | 5160 |
|
Other funds holding FBIO
OM
VCM
SAM
GCP
BCM
Citadel Advisors's FBIO Position: Q1 2026 in Review
Citadel Advisors opened a new position in Fortress Biotech (FBIO) in Q1 2026: 180,289 shares worth $503K. The stake represents ﹤0.01% of the portfolio and ranks #9293 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in FBIO as recently as Q2 2025.
Citadel Advisors first reported a position in FBIO in Q3 2013 and has held it in 25 quarters since. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.
- Citadel Advisors held 180,289 shares of Fortress Biotech worth $503K as of Q1 2026.
- Fortress Biotech was a new Citadel Advisors position in Q1 2026.
- Fortress Biotech made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9293 holding.
- Citadel Advisors first reported a position in Fortress Biotech in Q3 2013 and has held it in 25 quarters since.
- 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.